According to the Zhitong Finance App, Chenguang Biotech (300138.SZ) released a performance forecast for the first three quarters of 2026. Net profit attributable to shareholders of listed companies for the first three quarters is expected to be 254 million yuan to 284 million yuan, a year-on-year decrease of 6.53%-16.40%.

In the first three quarters, the company gradually promoted various businesses and actively developed markets in accordance with the annual business plan. Among them: sales of red pepper increased year on year, but due to market influence, the gross margin of red pepper decreased by 2% compared to the previous year, and sales of chili pepper concentrate decreased by about 19% year on year.

In the third quarter, lutein ushered in an inflection point. Product sales and gross margin both increased year on year; the cottonseed business was affected by seasonal fluctuations and achieved year-on-year increases in revenue and profit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.